NEW YORK (GenomeWeb News) – Sigma-Aldrich plans to develop preclinical research models of Parkinson's disease through a research grant from the Michael J. Fox Foundation, the foundation said today.

Sigma Advanced Genetic Engineering (SAGE) will use zinc finger nuclease technology to develop preclinical research models that after around one year of development time it plans to make available to the Parkinson's research community.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.